Metsera Inc.(MTSR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MTSR Metsera Inc.

已收盘 04-30 16:00:00 EDT

24.11

+0.81

+3.48%

盘后24.71

+0.60+2.49%

19:28 EDT

最高24.99	最低22.58	成交量87.10万
今开23.26	昨收23.30	日振幅10.34%
总市值25.33亿	流通市值14.46亿	总股本1.05亿
成交额2,082万	换手率1.45%	流通股本5,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":24.11,"timestamp":1746043200000,"preClose":23.3,"halted":0,"volume":870984,"hourTrading":{"tag":"盘后","latestPrice":24.71,"preClose":24.11,"latestTime":"19:28 EDT","volume":3930,"amount":95122.96,"timestamp":1746055715962},"delay":0,"floatShares":59968852,"shares":105050219,"eps":-14.490661,"marketStatus":"已收盘","change":0.81,"latestTime":"04-30 16:00:00 EDT","open":23.26,"high":24.99,"low":22.58,"amount":20822609.262096003,"amplitude":0.103433,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.490661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":5,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":23.3,"preHourTrading":{"tag":"盘前","latestPrice":22.9,"preClose":23.3,"latestTime":"09:27 EDT","volume":7395,"amount":176771.23362,"timestamp":1746019657277},"postHourTrading":{"tag":"盘后","latestPrice":24.71,"preClose":24.11,"latestTime":"19:28 EDT","volume":3930,"amount":95122.96,"timestamp":1746055715962},"volumeRatio":0.796836},"requestUrl":"/m/hq/s/MTSR","defaultTab":"news","newsList":[{"id":"2527160001","title":"Nucana Plc盘中异动 急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527160001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527160001?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:13","pubTimestamp":1744640000,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时13分，Nucana Plc股票出现波动，股价快速拉升5.31%。Nucana Plc股票所在的生物技术行业中，整体涨幅为1.35%。Nucana Plc公司简介：NuCana PLC是一家生物制药公司，专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药，旨在克服关键的抗癌机制，并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139","MTSR"],"gpt_icon":0},{"id":"2514097940","title":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097940?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MTSR"],"gpt_icon":0},{"id":"2511567929","title":"热闹的“2025减肥药第一股”，不属于我们","url":"https://stock-news.laohu8.com/highlight/detail?id=2511567929","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511567929?lang=zh_cn&edition=full","pubTime":"2025-02-13 13:54","pubTimestamp":1739426077,"startTime":"0","endTime":"0","summary":"2025年，美股第一家上市的减肥药biotech涨疯了。1月31日，Metsera上市首日，股价涨幅达到47.22%。在接下来的7个交易日里，股价继续上涨，最新市值已经突破30亿美元。而这一切，距离Metsera创立的2022年，不过3年时间。对于国内外众多押注GLP-1的biotech来说，这无疑也是他们梦寐以求的。公司的定位是“彻底改变肥胖治疗”，其核心布局分为两大类。所以，Metsera认为，MET-097i的给药周期，能延长至1个月1次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/250698","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["MTSR","BK1574","01477","BK1191","06978","BK4139","BK1161"],"gpt_icon":0},{"id":"2508925197","title":"Metsera纳斯达克上市：首日大涨47%，市值28亿美元，主治肥胖症","url":"https://stock-news.laohu8.com/highlight/detail?id=2508925197","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508925197?lang=zh_cn&edition=full","pubTime":"2025-02-01 18:26","pubTimestamp":1738405576,"startTime":"0","endTime":"0","summary":"临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250201/6387403112880683398066864.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250201/6387403112880683398066864.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n28924/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ARTL",".IXIC","MNQmain","NQmain","TQQQ","USAW.SI","MTSR","TSYW.SI","SQQQ","BK1147","BK4007","03086","NDX","USJW.SI","QLD","QID","NVIW.SI","PSQ"],"gpt_icon":1},{"id":"1191771744","title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191771744","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191771744?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:36","pubTimestamp":1738344987,"startTime":"0","endTime":"0","summary":"在医疗行业IPO活跃的大环境下,Metsera Inc. 于今日在美国纳斯达克成功上市,公司股价盘中大涨41.67%,引起了市场广泛关注。据报道,Metsera是一家临床阶段的生物技术公司,正在开发基于GLP-1机制和其他生物靶点的注射和口服药物来治疗肥胖症及相关疾病。在此次IPO中,公司以每股18美元的发行价共发行了1528万股,募资总额高达2.75亿美元。以发行价计算,Metsera的估值约为18.5亿美元。IPO后,这些机构将继续持有Metsera股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MTSR"],"gpt_icon":0},{"id":"2507326479","title":"Metsera今晚纳斯达克上市：发行价18美元 募资2.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507326479","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507326479?lang=zh_cn&edition=full","pubTime":"2025-01-31 16:24","pubTimestamp":1738311880,"startTime":"0","endTime":"0","summary":"临床阶段的生物技术公司Metsera(股票代码：“MTSR”）将于今日在美国纳斯达克上市，发行价为18美元，发行1528万股，募资总额为2.75亿美元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250131/6387393747620405815700744.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250131/6387393747620405815700744.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n28921/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ARTL","TSYW.SI","USAW.SI","NVIW.SI",".IXIC","03086","NDX","QLD","MTSR","NQmain","BK1147","SQQQ","PSQ","QID","TQQQ","MNQmain","BK4007","USJW.SI"],"gpt_icon":1},{"id":"2507331069","title":"医疗IPO活跃，今晚Metsera和Maze上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2507331069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507331069?lang=zh_cn&edition=full","pubTime":"2025-01-31 15:40","pubTimestamp":1738309211,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Metsera和Maze Therapeutics这两家制药商在周四公布了首次公开募股定价。根据一份声明，Metsera IPO定价为每股18美元，该公司将出售1530万股股票以筹资2.75亿美元。资料显示，Metsera是一家位于临床阶段的生物技术公司，开发治疗肥胖及相关疾病的注射和口服药物。该公司的最大股东是Third Rock Ventures的子公司，其他投资者包括ARCH Venture Partners的子公司等。在这个1月，Beta Bionics周三进行了2.04亿美元的IPO，亚盛医药于1月23日发行了1.26亿美元的美国存托股票。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245141.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MAZE","159891","MTSR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metsera.com","stockEarnings":[{"period":"1week","weight":0.0747},{"period":"1month","weight":-0.1679},{"period":"3month","weight":0.2944},{"period":"ytd","weight":0.2944}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Metsera, Inc.最初于2022年6月29日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，开发下一代注射和口服营养刺激激素，或NUSH，类似物肽，用于治疗肥胖、超重和相关疾病。","exchange":"NASDAQ","name":"Metsera Inc.","nameEN":"Metsera Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Metsera Inc.(MTSR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Metsera Inc.(MTSR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Metsera Inc.,MTSR,Metsera Inc.股票,Metsera Inc.股票老虎,Metsera Inc.股票老虎国际,Metsera Inc.行情,Metsera Inc.股票行情,Metsera Inc.股价,Metsera Inc.股市,Metsera Inc.股票价格,Metsera Inc.股票交易,Metsera Inc.股票购买,Metsera Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Metsera Inc.(MTSR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Metsera Inc.(MTSR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}